Overexpression and Amplification of c-myc during Progression of Human Colorectal Cancer

Oncology (Switzerland)

Volumn 53, Issue 6, 1996, Pages 448-454

  Rochlitz, Christoph F ^a   Herrmann, Richard ^a   De Kant, Eric ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amplification; c myc; Colorectal cancer; Gene regulation; Metastasis; Overexpression

Indexed keywords

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; METASTASIS; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA, NEOPLASM; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0029859480     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227619     Document Type: Article

References (50)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis, Cell 1990:61:759-767.
2. Bos JL, Fearon ER, Hamilton SR, Verlaan-de-Vries M, van Boom JH, van der Eb AJ, Vogel-stein B: Prevalence of ras gene mutations in human colorectal cancers, Nature 1987:327: 293-297.
3. Forrester K, Almogucra C, Pcrucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis, Nature 1987; 327:298-303.
4. Sikora K, Chan S, Evan G, Gabra H, Markham N, Stewart J, Watson J: C-myc oncogene expression in colorectal cancer, Cancer 1987:59: 1289-1295.
5. Heerdt BG, Molinas S, Deitch D, Augenlichl LH: Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the e-myc gene, Oncogene 1991:6:125-129.
6. Nishisho L, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge PH, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Prcisinger AC, Smith KJ, Su L-K, Kinzler KW, Vogelstein B: Mutations of chromosome 5q21 genes in FAB and colorectal cancer patients, Science 1991;253:665-669.
7. Erisman M, Rothberg P, Astrin S: Deregulation of c-myc gene expression in human colon carcinomas is not accompanied by amplification or rearrangement of the gene, Mol Cell Biol 1985: 5:1969-1976.
8. Finley GG, Schulz NT, Hill SA, Geiser JR, Pipas JM, Meisler Al: Expression of the myc gene family in different stages of human colorectal cancer, Oncogene 1989:4:963-971.
9. Croce C: Role of chromosome translocations in human neoplasia, Cell 1987:49:155-156.
10. Escot C, Theillet C, Callahan R: Genetic alterations of the c-myc protooncogene (myc) in human primary breast carcinomas, Proc Natl AcadSci USA 1986;83:4834-4838.
11. Johnson B, Ihde D, Minna J: Myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course, J Clin Invest 1987;79:1629-1634.
12. Yokota J, T-Yokota Y, Cline M: Alterations of myc, myb, and rasH proto-oncogenes in cancers are frequent and show clinical correlation, Science 1986:231:261-265.
13. Erisman MD, Scott JK, Watt RA, Astrin SM: The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines, Oncogene 1988;2:367-378.
14. Erisman MD, Scott JK, Astrin SM: Evidence that familial adenomatous polyposis gene is involved in a subset of colon cancers with a complemeniable defect in c-myc regulation, Proc Natl Acad Sci USA 1989;86:4264-4268.
15. Rodriguez-Alfageme C, Stanbridgc EJ, Astrin SM: Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer, Proc Natl Acad Sci USA 1992:89:1482-1486.
16. Pietenpol JA, Miinger K, Howley PM, Stein RW, Moses HL: Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor fil and by the retinoblastoma gene product, Proc Natl Acad Sci USA 1991:88:10227-10231.
17. Hamel PA, Gill RM, Phillips RA, Gallie BL: Transcriptional repression of the E2-contain-ing promoters EIIaE, c-myc, and RBI by the product of the RBI gene, Mol Cel! Biol 1992; 12:3431-3438.
18. Goodrich DW, Lee W-H: Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53, Nature 1992:360:177-179.
19. Michalovitz D, Halevy O, Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53, Cell 1990;62:671-680.
20. Fields S, Jang SK: Presence of a potent transcription activating sequence in the p53 protein, Science 1990:249:1046-1049.
21. Raycroft L, Wu HY, Lozano G: Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene, Science 1990;249:1049-1051.
22. Waitz W, Loidl P: Cell cycle dependent association of c-myc protein with the nuclear matrix, Oncogene 1991;6:29-35.
23. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, PrivesC, Vogelstein B: Identification of p53 as a sequence-specific DNA-bind-ing protein, Science 1991;252:1708-1711.
24. Roncn D, Rotter V, Reisman D: Expression from the murine p53 promoter is mediated by a factor binding to a downstream helix-loop-hclix recognition motif, Proc Natl Acad Sci USA 1991:88:4128-4132.
25. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C: Wild-type p53 activates transcription in vitro, Nature 1992;358:83-86.
26. Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni Y: Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif, Oncogene 1993;8:1183-1193.
27. Reisman D, Elkind NB, Roy B, Beamon J, Rotter V: C-Myc transactivatcs the p53 promoter through a required downstream CACGTG motif, Cell Growth Differ 1993:4:57-63.
28. Hermeking H, Eick D: Mediation of c-myc-induced apoptosis by p53, Science 1994;265: 2091-2093.
29. Rochlitz CF, Heidc I, Thiede C, Herrmann R, de Kant E: Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer mctastases, Ann Oncol 1995:6.981 -986.
30. Goelz SE, Hamilton SR, Vogelstein B: Purification of DNA from formaldehyde fixed and paraffin embedded human tissue, Biochem Biophvs RcsCommun 1985; 130:118-126.
31. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning, A Laboratory Manual, ed 2, New York, Cold Spring Harbor laboratories, 1989.
32. Neubauer A, Neubauer B, Liu E: Polymerase chain reaction based assay to detect allelic loss in human DNA: Lossofbeta-interferon gene in chronic myelogenous leukemia, NAR 1990:18: 993-998.
33. Rochlitz CF, de Kant E, Neubauer A, Heidc I, Bohmer R, Oertel J, Huhn D, Herrmann R: PCR-dctcrmined expression of the MDR1 gene in chronic lymphocytic leukemia, Ann Hcmatol 1992;65:241-246.
34. Gray PW, Goeddel DV: Human IFN-gamma gene sequence and structure, Basic Life Sci 1983:25:35-61.
35. Gazin C, Dupont dc Dinechin S, Masson JM, Martin P, Stehelin D, Galibert F: Nucleotide sequence of the human c-mvc locus: Provocative open reading frame within the first exon, EMBOJ 1984;3:383-387.
36. Giissow D, Rein R, Ginjaar I, Hochstcnbach F, Seemann G, Kotlman A, Ploegh HL: The human beta 2-microglobulin gene, Primary structure and definition of the transcriptional unit, J Immunol 1987:139:3132-3138.
37. Katz ED, Dong MW: Rapid analysis and purification of polymerase chain reaction products by high-performance liquid chromatography, Biotechniques 1990:8:546-555.
38. Glantz S: Primer of Biostatistics, ed 1, New York, McGraw-Hill Book, 1981.
39. Alitalo K, Koskinen P, Makcla TP, Sakscla K, Sistonen L, Winqvist R: myc oncogenes: Activation and amplification, Biochitn Biophvs Acta 1987:907:1-32.
40. Metzler SJ, Ahnen DJ, Battifora H, Yokota J, Cline M: Protooncogene abnormalities in colon cancers and adenomatous polyps, Gastroenterology 1992:92:1174-1180.
41. Komblau SM, Goodacrc A, Cabanillas F: Chromosomal abnormalities in adult nonendemic Burkitt's lymphoma and leukemia, 22 new reports and a review of 148 cases from the literature, Hentatol Oncol 1991;9:63-78.
42. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM: c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization, Am J Pathol 1995:146:1 Hill 39.
43. Little C, Nau M, Carney D, Gazdar A, Minna J: Amplification and expression of the c-myc oncogene in human lung cancer cell lines, Nature 1983:306:194-196.
44. Nau M, Carney D, Minna J: Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer, Curr TopMicrobiol Immunol 1984:113:172-177.
45. Brodeur G, Seeger R, Schwab M, Varmus H, Bishop M: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage, Science 1984:224: 1121-1124.
46. Seeger R, Brodeur G, Sather H, Dalton A, Siegel S, Wong K, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, N Engl J Med 1985;313:1111-1116.
47. Klefstrom J, Vastrik I, Sakscla E, Valle J, Eilcrs M, Alitalo K: c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha, EMBOJ 1994;13:5442-5450.
48. Rochlitz CF, Heidc I, de Kant E, Bohmer R, Peter FJ, Neuhaus P, Huhn D, Herrmann R: Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinoma, Oncology 1993:50:70-76.
49. Heice I, Thiede C, Poppe K, de Kant E, Huhn D, Rochlitz CF: Expression and mutational analysis of nm23-Hl in liver mctastases of colorectal cancer, Br J Cancer 1994:70:1267- 1271.
50. Wagner AJ, Kokontis JM, Hay N: Myc-me-diated apoptosis requires wild-type p53 in a manner independent of cell cylce arrest and the ability of p53 to induce p21/wafl/cip I, Genes Dev 1994:8:2817-2830.